KPV vs VIP
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Lys-Pro-Val, Alpha-MSH fragment
A tripeptide derived from alpha-melanocyte stimulating hormone (α-MSH). Known for potent anti-inflammatory effects, particularly in the gut.
Also: Vasoactive Intestinal Peptide, Aviptadil
A naturally occurring peptide with immunomodulatory and anti-inflammatory effects. Being studied for ARDS, pulmonary hypertension, and autoimmune conditions.
Key Comparison Insights
- Both peptides belong to the Immune category, suggesting similar primary applications.
- VIP has stronger research evidence (Human Trials) compared to KPV (Animal Studies).
Detailed Comparison
| Attribute | KPV | VIP |
|---|---|---|
| Category | Immune | Immune |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | KPV retains the anti-inflammatory properties of α-MSH without melanocortin receptor activation. It inhibits inflammatory pathways including NF-κB, reduces pro-inflammatory cytokines, and has antimicrobial properties. | VIP binds to VPAC1 and VPAC2 receptors, triggering anti-inflammatory cascades. It relaxes smooth muscle, vasodilates, inhibits pro-inflammatory cytokines, and promotes regulatory T-cell function. Has broad immunomodulatory effects. |
| Common Dosing | 200-500 mcg daily 1-2x daily | 50-100 mcg intranasal daily 1-2x daily, intranasal |
| Administration | Subcutaneous injection or oral (capsules) | IV infusion, inhaled, or intranasal |
| Typical Duration | 4-8 weeks typical | Variable by indication |
| Best Time to Take | Morning or as directed | Morning or as directed |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Studies show effectiveness in inflammatory bowel disease models. Research demonstrates wound healing acceleration and antimicrobial activity. Being investigated for gut health and inflammatory conditions. | Clinical trials for COVID-19 ARDS showed promising results. Research demonstrates benefits in pulmonary arterial hypertension. Studies show potential for autoimmune conditions like rheumatoid arthritis and inflammatory bowel disease. |
Frequently Asked Questions: KPV vs VIP
What is the difference between KPV and VIP?
KPV is a immune peptide that a tripeptide derived from alpha-melanocyte stimulating hormone (α-msh). known for potent anti-inflammatory effects, particularly in the gut. VIP is a immune peptide that a naturally occurring peptide with immunomodulatory and anti-inflammatory effects. being studied for ards, pulmonary hypertension, and autoimmune conditions. The main differences lie in their mechanisms of action and clinical applications.
Which is better, KPV or VIP?
Neither is universally "better" - the choice depends on your specific goals. KPV is typically used for immune purposes, while VIP is used for immune. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can KPV and VIP be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using KPV and VIP together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.
Related Comparisons
View Full Peptide Profiles
Educational Information Only
This comparison of KPV and VIP is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.